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Abstract 
A dietary deficiency of copper (CUD) is associated with a 50-70% and a 2-fold increase in hepatic reduced glutathione (GSH) 
concentration a d synthesis, respectively, which leads to a 50-80% increase in plasma GSH. Moreover, the kidneys of CuD rats remove 
40% more GSH from the blood than copper adequate (CuA) rats. These findings have led us to propose that the increase in hepatic 
synthesis of GSH in CuD rat'.~ is accompanied by a comparable increase in the hepatic expression of ~/-glutamylcysteine synthetase 
(~/-GCS), the rate limiting enzyme of glutathione biosynthesis, and that the enhanced uptake of GSH by the kidney would lead to a 
compensatory decrease in renal ~-GCS expression. In experiment I, male weanling rats (3-4 weeks) were ad libitum fed a CuD (0.5 Ixg 
Cu/g) or CuA (5.8 Ixg/g) diet for 70 days; and in experiment II, male weanling rats were pair-meal fed the CuD or CuA diet for 35 
days. In both studies, CuD diet caused a significant increase in hepatic GSH concentration, but hepatic 3,-GCS activity and mRNA 
abundance were unchanged. In contrast, renal GSH concentration was unaffected by the CuD diet. However, renal ~/-GCS activity was 
reduced 40% and this was paralleled by a 50% decrease in ~/-GCS mRNA. Moreover, the decrease in renal ~/-GCS mRNA was caused by 
a reduction in renal ~/-GCS gene transcription. The results of these studies indicate that the increase in renal uptake of GSH resulting from 
a dietary Cu deficiency is associated with a compensatory decrease in "y-GCS expression. 
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1. Introduction 
GSH is the most abundant cellular peptide and non-pro- 
tein thiol that plays a vil:al role in defending the cell 
against toxins and free radicals [1]. GSH is synthesized 
from its constituent amino acids in two sequential ATP-de- 
pendent reactions catalyzed by the rate-determining en- 
zymes ~/-glutamylcysteine synthetase and GSH synthetase 
[2]. Recently, we demonstrated that dietary copper defi- 
ciency was associated with 2- to 3-fold increase in hepatic 
GSH synthesis and secretion [3], and 50-70% increase in 
hepatic GSH concentration [4]. The increase in hepatic 
GSH synthesis and release appears to be associated with a 
copper deficiency and may be a compensatory response 
* Corresponding author. Fax: + 1 (512) 4715630. 
resulting from the oxidative stress of copper deficiency 
caused by copper depletion from cytosolic superoxide 
dismutase. 
Approximately two thirds of plasma GSH is extracted 
from the plasma via renal GSH transpeptidase activity with 
subsequent degradation to its constituent amino acids [2]. 
Moreover, the kidney of copper deficient rats removes 
40% more GSH from arterial plasma than in copper ade- 
quate rats [5]. In light of the fact that a dietary copper 
deficiency increases hepatic GSH synthesis and secretion 
[3,4], and that the kidneys of copper deficient rats remove 
a greater amount of plasma GSH, we hypothesized that the 
expression of the rate limiting enzyme of GSH synthesis, 
i.e., ~-glutamylcysteine synthetase (~/-GCS), was increased 
in the liver of copper deficient rats, while its expression in 
the kidney of copper deficient rats was decreased in re- 
sponse to the greater enal GSH uptake. 
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2. Materials and methods 
2.1. Materials 
Diet components were obtained from the United States 
Biochemical Corporation (Cleveland, Ohio). The human 
GCS cDNA (pSKGCS-1) was generously provided by Dr. 
R. Timothy Mulcahy, Univ. of Wisconsin, phospho- 
enolpyruvate carboxy kinase (pBR-pPCK 10) was gener- 
ously provided by R. Hanson, Case Western University, 
and [3-actin cDNA (pRBactin-10) was generously provided 
by Dr. Kedes, Stanford University. RNAzol B was ob- 
tained from Biotecx (Houston, TX). [a-32p]dCTP was 
purchased from Dupont/NEN. Random primers cDNA 
labelling kit was purchased from Gibco BRL (Gaithers- 
berg, MD). Bio-Rad (Richmond, Ca) protein assay kit was 
used for determination f protein amount. All other chemi- 
cals were obtained from Sigma Chemicals Co (St. Louis, 
MO). 
2.2. Animal care and diets 
Weanling male Sprague-Dawley rats weighing 30-40 g 
were purchased from Charles River (Boston, MA). They 
were housed individually in stainless steel cages in an 
animal facility, 12 h light/dark cycle, 18-22°C, 45% 
relative humidity. Food intake was measured aily and 
body weight was monitored weekly. Cages, water bottles, 
and food containers were rinsed with 2 mM EDTA and 
deionized water before use to remove trace mineral con- 
taminants. 
The diet was formulated to meet he recommendation f 
the American Institute of Nutrition (AIN) [6,7] and con- 
tained by weight 20% casein, 67.3% sucrose, 5.0% corn 
oil, 3.0% cellulose, 3.5% copper- and zinc-free AIN min- 
eral mix (AIN 76A) and 1.0% vitamin mix (AIN 76). This 
basal diet contained 6.0 ppm zinc and 0.5 ppm copper. The 
zinc content of the diet was supplemented with 15 ppm 
zinc, as Zn(CH3COO) 2• 2 H20 to obtain intended concen- 
trations of approx. 21 ppm zinc. The basal diet served as 
the copper deficient (CUD) diet, while the copper adequate 
(CuA) diet was prepared by supplementing the basal diet 
with CuS04 • 5 H20 to a level of 6 ppm. Zinc and copper 
content of the diets were analyzed by flame atomic absorp- 
tion spectrophotometry, as previously described [4]. The 
copper deficient diet contained 0.5 I~g Cu/g diet and the 
copper adequate diet contained 5.8 Ixg Cu/g diet. Both 
diets contained, by analysis, 23.9 Ixg Zn/g diet. 
In experiment I, male Sprague Dawley rats were ad 
libitum fed a CuD or CuA diet for 70 days. In experiment 
II, rats were pair meal-fed (3 h/day, 10:00 h to 13:00 h) in 
reversed light/dark cycle) the CuD or CuA diet for 35 
days [8]. In this design rats were paired according to body 
weight, and food was allotted to each pair based upon the 
lower intake of the previous day. The meal feeding regi- 
men provides a metabolically homogeneous population, 
and reduces animal to animal variability in gene expres- 
sion caused by variations among animals in eating behav- 
ior. Results did not differ between ad libitum and meal- 
trained animals. 
2.3. T-GCS enzyme actit~ity 
The activity of GCS was determined as described by 
Sekura and Meister [17]. Tissue samples, 0.2 g, were 
homogenized in 4 vol of 0.2 M Tris/HC! buffer, pH 8.0. 
After centrifugation 2 times at 10000 × g for 20 min each 
at 4°C. The reaction mixtures contained Na 2 ATP (5 mM), 
sodium glutamate (10 mM), L-a-aminobutyrate (10 mM), 
Na2EDTA (2 mM), MgCI 2 (20 mM), Tris/HCl buffer 
(100 mM, pH 8.2), NADH (0.2 mM), pyruvate kinase (17 
Ixg) and lactate dehydrogenase (17txg) in a final volume of 
1 ml. The reaction was started by adding enzyme source 
(1-2 mg protein) to the reaction mixture and the decrease 
in absorbance at 340 nm was followed. Appropriate con- 
trols in which the enzyme and L-a-aminobutyrate were 
separately omitted were performed. Protein was deter- 
mined by the Bradford method [18]. The enzyme activity 
was expressed as Ixmol NADH/h per mg protein. 
2.4. y-GCS mRNA measurements 
RNA was extracted from freshly frozen liver and kid- 
ney by the quanidinuim isothiocyanate-phenol procedure 
of Chomzynski and Sacchi [9]. The precipitated RNA was 
washed with 75% ethanol and dissolved in a highly puri- 
fied and stabilized formamide. Because of the low abun- 
dance of GCS mRNA in the liver, hepatic GCS mRNA 
abundance was determined using poly(A ÷) enriched RNA 
[10]. On the other hand the high abundance of GCS mRNA 
in the kidney permitted quantification of the GCS mRNA 
abundance by Northern analysis using total RNA. The 
RNA (20 txg each for total RNA; 5 ~g each for poly(A ÷) 
RNA) was size fractionated by electrophoresis on a 1.2% 
agarose gel containing 6.6% formaldehyde, 20 mM Mops, 
1 mM EDTA, and 1 mM sodium acetate, according to the 
modified procedures of Selden [11]. After electrophoresis, 
the RNA was electroblotted onto Zeta Probe GT mem- 
brane (Bio-Rad, Richmond, CA) and fixed to the mem- 
brane by UV cross-linking. The quantity of ~/-GCS mRNA 
was determined by Northern blotting analysis as previ- 
ously described [12]. The cDNA probes were labeled by 
random primers labeling method [13]. Stringency washes 
were conducted as previously described [12] and the mem- 
brane was exposed to Kodak X-Omat AR film (Rochester, 
NY). Bands were quantified by Ambis imaging system 
(San Diego, CA). 
2.5. Renal y-GCS transcription rate 
The impact of a CuD diet on kidney "y-GCS gene 
transcription was evaluated by nuclear un-on assays using 
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two sets of pooled nuclei t13 rats per set) prepared from 
fresh kidneys of rats fed CuD or CuA diets for 70 days. 
Approx. 60 Az60/ml of nuclei were stored in - 80°C in a 
storage buffer containing 50 mM Hepes, pH 7.5, 50% 
glycerol, 75 mM NaCI, 0.1 mM EDTA, 5 mM dithio- 
threitol and 0.1 mM phenylmethylsulfonylfluoride. Th  in 
vitro nuclear transcription r n-on assay was a modification 
of the procedure described by Shupnik et al. [14]. Previ- 
ously frozen nuclei, 133 I~1 (60 A260 U/ml), were thawed 
on ice, incubated at 26°C for 1 min and added to 167 txl of 
pre-warmed (26°C) reaction mixture containing 20% glyc- 
erol, 75 mM Hepes, pH 7.5, 15 mM NaC1, 60 mM KC1, 3 
mM MgC12, 0.5 mM spermine, 1mM spermidine, 0.5 mM 
EDTA, 0.1 mM EGTA, 0.5 mM dithiothreitol, 0.5 mM 
ATP, 0.5 mM CTP, 0.5 mM GTP, 0.5 p~M cold-UTP, 50 
IxCi [e~-32p]UTP (3000 Ci/mmol, NEN Dupont), 130 
U/ml RNasin (Promega, Madison, WI), 10 p~M creatine 
phosphate, 32 U/ml  creatine frnctokinase in a final vol- 
ume of 300 Ixl. The reaction was run for 20 min at 26°C. 
Purification of nascent transcripts was done by the method 
of Linial et al. [ 15]. 32 P-Labelled transcripts were extracted 
twice with phenol/chloroform/isoamylalcohol (25:24:1) 
and once with chloroform/isoamylalcohol (24:1). Precipi- 
tation of [32p]RNA was done with isopropanol. The la- 
beled RNA was resuspended in 100 Ixl of 10 mM Tris-C1, 
1 mM EDTA, pH 8.0, and lhen unincorporated nucleotides 
were removed by exclusion chromatography. Each filter 
was hybridized with same number of cpm. 
The cDNA plasmid for, ~-GCS (pBSKGCS-1), phos- 
phoenolpyruvate carboxykinase (pBR-pPCK 10), [3-actin 
(pBR-BA1), and pBS plasrnid (for control) were denatured 
in 0.4 N NaOH for 10 min at room temperature, neutral- 
ized in 6 X SSC, and 2 Ixg per slot was applied to Zeta 
probe membrane (BioRad, Rockville Centre, NY) using 
slot blot apparatus. Labelled nuclear run-on RNA was 
hybridized to slot-blotted membranes in a 2 ml of buffer 
containing 50% deionized formamide, 5 × SSC (20 X stock 
solution is 3 mol/ l  NaC1, 0.3 mol/1 sodium citrate, pH 
7.0), 5 X Denhardt's (100 × stock solution is 2% Ficoll, 
2% polyvinylpyrrolidone, 2% bovine serum albumin), 50 
mM sodium phosphate buffer (pH 6.5), 1 mM EDTA (pH 
8.0), 5% SDS, 250 ~g/ml  yeast t-RNA and 250 p~g/mi 
heat-denatured salmon testes DNA at 38°C for 72 h. The 
membranes were washed briefly at room temperature in
2 × SSC and 0.1% SDS, followed by washing 3 times for 
30 rain each in 0.1 X SSC, 0.1% SDS at 60°C. The 
membranes were air-dried and subjected to autoradiog- 
raphy for 5 days. Levels of hybridization were quantified 
by AMBIS image acquisition analysis system (San Diego, 
CA). 
2.6. GSH determination 
Frozen liver and kidney (about 0.2 g) were homoge- 
nized in 100 mM citrate buffer, pH 5.0, 5 mM EDTA and 
centrifuged 13 000 x g. For the determination f total glu- 
tathione (GSH + 2 GSSG), tissue homogenates were de- 
proteinized with 0.5 vol. of 10% (w/v) aqueous 5-sulfo- 
salicylic acid and buffered to pH 7.4 with 50% aqueous 
triethanolamine. Total glutathione was determined by the 
dithionitrobenzoic a id (DTNB) recycling assay [16]. Sam- 
ples, 700 ixl of 0.3 mM NADPH, 100 Ixl of 10 mM DTNB 
and appropriate amount of phosphate buffer was added to 
a 1-cm light path cuvette. Then, the reaction was started 
with the addition of 20 Ixl of 50 U/ml  glutathione reduc- 
tase. Change in absorbance was measured at 412 nm. GSH 
values were expressed as ixmol/g tissue. All samples and 
GSH standards contained equal amount of 5-sulfosalicylic 
acid and triethanolamine. 
2.7. Mineral analysis 
In Experiment I, tissue Cu, Zn, and Fe were analyzed 
by flame atomic absorption spectrophotometry (Instrumen- 
tation Laboratories, Model 257, Wilmington, MA) of 
lyophilized, dry ashed (550°C for 15 h) tissue samples. 
Values were validated by analysis of standard bovine liver 
samples (National Institutes of Standard and Technology, 
Gaithersburg, MD). In Experiment II Cu concentrations 
were estimated by analysis of tissue homogenates u ed for 
GCS activity measurements. 
2.8. Statistical analysis 
Data from all groups of the rats were expressed as 
mean ___ SEM. Statistical analyses of the significance of 
differences between means of the groups were tested by 
Student's t-test. 
3. Results and discussion 
3.1. Hepatic GSH and T-GCS expression 
Feeding the CuD diet for either 70 or 35 days had no 
significant effect on body weight gain but did result in the 
depletion of copper from the liver and kidney (Table 1). 
Interestingly, hepatic Fe was increased nearly 2-fold, while 
renal Fe was significantly reduced (Table 1). The recipro- 
cal changes in hepatic Cu and Fe were accompanied by a 
significant increase in hepatic level of GSH (Table 1). The 
rise in hepatic GSH is a characteristic feature of a dietary 
copper deficiency [3-5], and appears to be the result of a 
2- to 3-fold increase in hepatocyte GSH synthesis [3]. The 
reason for the induction of hepatic GSH synthesis is 
unclear, but may be in response to greater cellular oxida- 
tive stress caused by copper depletion and inactivation of 
Cu, Zn-superoxide dismutase [3-5]. Alternatively, the in- 
crease in GSH could be a response to an increased oxida- 
tive stress resulting from the doubling of hepatocyte Fe 
(Table 1). The mechanism responsible for the enhanced 
production of hepatic GSH also remains unclear, because 
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Table 1 
Hepatic and renal copper, zinc, iron, and GSH concentrations in rats fed 
CuD and CuA diets for 70- or 35-days 
Copper adequate Copper deficient 
70-day copper treatment (n = 5): 
Kidney 
Copper (~mol/g dry) 0.36+0.03 0.18+0.02 ~ 
Zinc (IX mol/g dry) 1.32 + 0.01 1.26 + 0.01 
Iron (~mol/g dry) 0.88 + 0.02 0.64 ± 0.06 * 
GSH (Ix mol/g wet) 1.58 ± 0.24 1.21 + 0.41 
Liver 
Copper (ixmol/g dry) 0.20±0.02 0.07+0.01 * 
Zinc (~mol/g dry) 1.28 ± 0.07 1.27 ± 0.30 
Iron (Ixmol/g dry) 1.21 +0.07 2.43 +0.02 * 
GSH (~mol/g wet) 4.06. ± 0.24 5.36 ± 0.11 * 
35-day copper treatment (n = 3): 
Kidney 
Copper (tzmol/g dry) 0.28+0.02 0.11 ±0.004 *
GSH (1~ mol/g wet) 1.08 ± 0.24 1.21 ± 0.18 
Liver 
Copper (ixmol/g dry) 0.11+0.02 0.04±0.004 * 
GSH (l~mol/g wet)  3.02±0.19 5.55 ___0.42 * 
Tissue Cu, Zn, Fe, and GSH concentrations were measured from 12-h 
fasted CuA and CuD rats. Values are expressed as mean-t-SEM for 
n = 5, 70-day study; and n = 3, 35-day study. * Significantly different 
from the CuA rats. 
the hepatic expression of the rate limiting enzyme in the 
GSH synthetic pathway, "~-GCS, was unaffected by dietary 
copper status (Figs. 1 and 2). Since ~/-GCS is covalently 
modified by hormone dependent phosphorylation [19], it is 
possible that copper depletion enhanced ~/-glutamylcy- 
steine synthesis by increasing the in vivo catalytic effi- 
ciency of the hepatic ",/-GCS enzyme by a mechanism 
(e.g., substate availability or post-translation phosphoryla- 
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Fig. 1. Hepatic ~/-GCS activity after 70- and 35-days of copper defi- 
ciency. Hepatic ~/-GCS activity was measured in 12-h fasted rats. Values 
are expressed asmean + SEM for n = 5, 70-day study, and n = 3, 35-day 
study. At both 70-day and 35-day, no significant differences between 
CuA and CuD, P < 0.05. 
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Fig. 2. Hepatic 3,-GCS mRNA concentration after 70- and 35-days of 
copper deficiency. Abundance of hepatic ~-GCS mRNA in 12 h fasted 
rats as determined byNorthern analysis. Loading differences were ad- 
justed using 13-actin hybridization. Values are expressed asmean_+ SEM 
for n= 5, 70-day study, and n= 3, 35-day study. At both 70- and 
35-day, no significant differences between CuA and CuD, P < 0.05, 
tion) which could not be detected within the enzymatic 
assay for ~-GCS activity. 
3.2. Rena l  GSH and  T -GCS express ion  
There is a considerable amount of interorgan transport 
of GSH from the liver to a variety of tissues [2]. Moreover, 
the kidneys of CuD rats remove 40% more GSH from the 
blood than do CuA rats [5]. However, total kidney GSH 
concentrations were not different between CuD and CuA 
rats (Table 1). Thus, in order to maintain constant renal 
GSH levels during a copper deficiency, we hypothesized 
that the expression of kidney "y-GCS was reduced in 
response to dietary Cu-deficiency. In support of this hy- 
pothesis, we found that the enzymatic activity of kidney 
",/-GCS was decreased approx. 40% in rats fed a CuD diet 
for 70 days (Fig. 3), and that the reduction in ",/-GCS 
activity was paralleled by a comparable drop in ~-GCS 
mRNA concentration (Fig. 4). Nuclear run-on assays re- 
vealed that the decrease in "y-GCS mRNA concentration 
resulted from a significant (P  < 0.05) inhibition of renal 
",/-GCS transcription (Fig. 5). Moreover, the suppression of 
kidney ",/-GCS expression in response to a CuD-diet was 
clearly present after 35 days of copper deficiency (Figs. 3 
and 4). The ~-GCS response to the CuD diet was not the 
result of a generalized non-specific suppression of renal 
gene expression because the mRNA abundance for [3-actin 
was unaffected by dietary copper deficiency. Interestingly, 
the 40% increase in GSH uptake by the kidneys of CuD 
rats [5] was nearly identical to the 40-50% reduction in 
kidney ~/-GCS activity and "y-GCS mRNA (Figs. 3 and 4). 
This suggests that a GSH feedback control mechanism 
may modulate the expression of kidney ~/-GCS through 
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Fig. 3. Renal y-GCS activity after 70- and 35-days of copper deficiency. 
Renal y-GCS activity was measured in 12-h fasted rats. Values are 
expressed as mean+_SEM for n= 5, 70-day study, and n= 3, 35-day 
study. ~ Significantly different from CuA, P < 0.05. 
transcriptonal control mechanism. In addition, GSH 
metabolism and y-GCS expression would appear to be a 
response to a copper deficSiency which is specific for the 
kidney. 
In summary, we previously demonstrated that a dietary 
copper deficiency enhanced hepatic GSH synthesis 2-fold 
CuA CuD 
"~-GCS 
13-actin 
PepCK 
PBS 
B. 
Renal v-GCS transcription_ arbitrary unit 
Cu adequate Cu deficient 
y-GCS 414 - 443 228 - 257 
13-actin 457 - 514 471 - 586 
PepCK 3429 - 357I 2714 - 3715 
Fig. 5. Renal 3'-GCS transcription run-on assay from 70-day copper 
deficient rats. Transcription rate of renal "y-GCS in 12 h fasted rats from 
70-day study was determined by nuclear un-on assays. A. Representative 
picture of run-on assays. 13-actin and phosphoenolpyruvate carboxkinase 
(PepCK) were measured to examine the specificity of effect and alter- 
ations in insulin/glucagon action and eating behavior, pBS plasmid was 
used for the specificity of binding. CuA: copper adequate. CuD: copper 
deficient, pBS: pBluescript plasmid. B. Summary table of replicate assays 
where two sets of pooled kidneys (n = 3 rats per set) were utilized in 
measures of gene transcription (i.e., n = 2 per treatment). Data are 
expressed as means + SD for pooled samples. Asterisk denotes value is 
significantly lower P < 0.05, one tailed t-test. 
- + + + Cu 
y- GCS 
2.3 2.0 2.1 3.8 4.3 4.0 
13-actin 
Arbitrary unit (•-GCS) 
B. 
Renal mRNA concentration, arbitrary_ unit 
Cu adequate Cu deficient 
70-day 2.69 ± 0.72 1.43 ± 0.30* 
35-day 4.03 4- 0.45 2.13 4- 0.32* 
Fig. 4. Renal ~/-GCS mRNA concentration after 70- and 35-days of 
copper deficiency. Abundance of renal y-GCS mRNA in 12-h fasted rats 
was determined by Northern blot analysis using 20 I-~g of total RNA per 
lane. Loading differences were adjusted using 13-actin hybridization. A. 
Representative Northern blot autoradiogram from samples of 35-day 
study. The positions of ~/-GCS and 13-actin mRNA are indicated ( + ) and 
( - )  refer to CuA and CuD rats, respectively. Densitometric counts for 
y-GCS mRNA corrected for loading efficiency are shown below each 
lane. B. Summary table for sample size of n = 5, 70-day study, and 
n = 3, 35-day study. * Significantly different from CuA rats, P < 0.05. 
[3], increased hepatic GSH concentrations 50-70% [4], and 
increased renal uptake of GSH 40% [5]. Interestingly, the 
induction of hepatic GSH production is not accompanied 
by an increase in hepatic ~-GCS activity (Fig. 1) or 
y-GCS mRNA (Fig. 2). However, the 40% increase in 
kidney uptake of GSH is associated with 40-50% decrease 
in kidney y-GCS activity (Fig. 3), caused by an inhibition 
of y-GCS gene transcription (Fig. 5) and an accompanying 
decrease in ~-GCS mRNA (Fig. 4). The sum of these 
changes results in no net change in kidney GSH concentra- 
tions (Table 1). Thus, it appears that renal GSH homeosta- 
sis is maintained by the regulation of GSH uptake and 
feedback control of the expression of y-GCS expression. 
The mechanism by which GSH modulates y-GCS expres- 
sion can only be speculated, but recent evidence suggests 
that the thiol redox status of cysteines in pivotal transcrip- 
tion factors (e.g., NF K B and fos/jun) alters DNA/protein 
interactions and functionally changes rates of gene tran- 
scription [20,21]. Thus, the increased uptake of renal GSH 
may modify the thiol redox of a transcription factor for the 
y-GCS gene, and thereby alter its interactions with its 
response lement in such a way as to reduce the rate of 
y-GCS gene transcription. Such a mechanism is clearly 
speculative, and can only be demonstrated after mapping 
the regulatory elements operating in the expression of the 
renal y-GCS gene. 
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